Hepatogastro

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Crohn's disease2 trials
• Ulcerative colitis2 trials

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• Abivax S.A.2 trials
• Janssen Research & Development, LLC2 trials

Running trials

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· Phase 3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

  NCT05507216· Phase 3· Abivax S.A.· Source